Longeveron Inc. (LGVN)
Last updated: 2026-10-22 22:58:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Longeveron Inc. (LGVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.55, with a market capitalization of $4.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $12.30. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$4.78M | |
$1.41 | |
$4,500.00 | |
$1.31 | |
$1.43 | |
71.52K | |
102.83K | |
-- | |
$12.30 | |
$1.31 | |
-- | |
-- |
Longeveron Inc. (LGVN) After-Hours Stock Price
Longeveron Inc. (LGVN) is trading at $1.52 in after-hours trading as of 2026-10-22 22:54:00, up 6.22% ($0.09) from the regular-session close of $1.43.
After-hours trading shows how investors are pricing LGVN after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Longeveron Inc. (LGVN) 7-Day Stock Price Change
Over the past seven days, Longeveron Inc. (LGVN) moved from $2.15 to $1.55, representing a decline of 28.05% ($0.60).
The stock traded between $1.31 and $2.45 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 89.26 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
LGVN 52-Week Price Position
Position in Range: 2.2%
LGVN is currently trading at $1.55, placing it 2.2% of the way from its 52-week low of $1.31 to its 52-week high of $12.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Longeveron Inc. (LGVN)?
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Longeveron Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Longeveron Inc. (LGVN) Stock on MEXC
Eligible investors can buy real shares of Longeveron Inc. (LGVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Longeveron Inc. (LGVN) stock price today?
2.Is LGVN stock going up or down today?
3.What is LGVN pre-market price?
4.What is LGVN after-hours price?
5.Is LGVN stock trading now?
6.Where does LGVN sit relative to its 52-week high and low?
7.What sector is Longeveron Inc. in?
8.What is Longeveron Inc.'s market capitalization and where is it listed?
9.How is LGVN valued in terms of P/E ratio and EPS?
10.Does Longeveron Inc. pay a dividend?
Explore More US Stocks
Search Stocks
LGVN Stock Calculator
Estimate the value between LGVN shares and USD.
LGVN Shares to USD
1.00 LGVN shares = 1.547 USD
Calculations are estimates based on the latest available price and are for reference only.



